YD Bio Ltd cash flow statement

In fiscal 2025, YD Bio Ltd's operations generated −$6.6m of cash; it spent $1.4m on capital projects, leaving free cash flow of −$8.0m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

YD Bio Ltd: cash flow statement, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash from operations	−0	−1	−7
Depreciation and amortisation	0	0	0
Stock-based pay	—	—	0
Capital spending	0	0	1
Free cash flow	−0	−1	−8
Free cash flow after stock pay	—	—	−8
Shares issued	—	8	13

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ISPC vs YDES QSI vs YDES BGLC vs YDES ACON vs YDES

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from YD Bio Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to YD Bio Ltd.